.
MergerLinks Header Logo
Cover Image Michael Riella
Michael RiellaCovington & Burling

Michael Riella

Partner at Covington & Burling

Lawyer

Washington

Deal Bio

Total Deals15
Valued Deals13
Total Value£33,606M
Avg. Deal Size£2,585M

Awards

2021 Top Healthcare Lawyers in North America

Expertise (15)

Key Relationships

United States
Biotechnology
Cross BorderAcquisitionMajorityPublicTender Offer
Arqule

target

Arqule

Merck Kgaa

bidder

Merck Kgaa

£2,054m

62 dealmakers

Austria
Biotechnology
AcquisitionPrivateMajorityCross BorderDisposalVenture CapitalPrivate Equity
Themis Bioscience

target

Themis Bioscience

Merck & Co

bidder

Merck & Co

value n/a

37 dealmakers

United States
Biotechnology
Reverse TakeoverMergerAcquisitionDomesticPrivateDe-SPACPrivate Equity
HUMACYTE

target

HUMACYTE

Alpha Healthcare Acquisition

bidder

Alpha Healthcare Acquisition

£618m

48 dealmakers

United States
Biotechnology
AcquisitionPublicDomesticMajorityTender Offer
Pandion Therapeutics

target

Pandion Therapeutics

Merck & Co

bidder

Merck & Co

£1,308m

28 dealmakers

United States
Pharmaceuticals
PublicMajorityAcquisitionDomestic
Kindred Biosciences

target

Kindred Biosciences

Elanco Animal Health

bidder

Elanco Animal Health

£312m

33 dealmakers

United States
Biotechnology
DomesticMajorityAcquisitionPublic
Acceleron Pharma

target

Acceleron Pharma

Merck & Co

bidder

Merck & Co

£8,528m

80 dealmakers

United States
Biotechnology
DomesticPrivateAcquisitionMajority
Motus Biosciences

target

Motus Biosciences

Insmed

bidder

Insmed

£201m

31 dealmakers

United States
FinTech
MergerMajorityPrivateReverse TakeoverDomesticAcquisitionDe-SPAC
Griid Infrastructure

target

Griid Infrastructure

Adit Edtech Acquisition

bidder

Adit Edtech Acquisition

£2,478m

29 dealmakers

United States
Renewable Energy Equipment
Spin OffPrivateDomesticMajorityPrivate EquityAcquisition
Borrego (development Business)

target

Borrego (development Business)

Energy Capital Partners

bidder

Energy Capital Partners

value n/a

48 dealmakers

United States
Biotechnology
MajorityAcquisitionPrivateCross Border
TENEOTWO

target

TENEOTWO

Astrazeneca

bidder

Astrazeneca

£1,048m

14 dealmakers

United States
Biotechnology
MajorityAcquisitionCross BorderPublicPrivate Equity
Cincor Pharma

target

Cincor Pharma

Astrazeneca

bidder

Astrazeneca

£1,487m

79 dealmakers

United States
Biotechnology
AcquisitionMajorityPrivateDomestic
Pfizer (preclinical Gene Therapy Programs)

target

Pfizer (preclinical Gene Therapy Programs)

Alexion Pharmaceuticals

bidder

Alexion Pharmaceuticals

£779m

14 dealmakers

United States
Biotechnology
MergerPublicAcquisitionDomesticMajority
Karuna Therapeutics

target

Karuna Therapeutics

Bristol Myers Squibb Company

bidder

Bristol Myers Squibb Company

£11,026m

54 dealmakers

United States
Biotechnology
AcquisitionDomesticMajorityPublicTender Offer
RAYZEBIO

target

RAYZEBIO

Bristol Myers Squibb Company

bidder

Bristol Myers Squibb Company

£3,228m

36 dealmakers

United States
Biotechnology
AcquisitionDomesticMajorityPublic
Harpoon Therapeutics

target

Harpoon Therapeutics

Merck & Co

bidder

Merck & Co

£534m

62 dealmakers

Sign up for a free trial account to enjoy the full Mergerlinks experience
Identify industry experts, connect with verified professionals, forge new relationships.
Sign Up

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US